FILANA THERAPEUTICS, INC. (FLNA) › Shareholders' EquityFILANA THERAPEUTICS, INC. (FLNA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $104.29M2009: $108.25M2010: $32.93M2011: $44.39M2012: $13.14M2013: $48.30M2014: $40.06M2015: $29.37M2016: $18.64M2017: $9.70M2018: $19.63M2019: $22.10M2020: $92.20M2021: $253.91M2022: $227.54M2023: $137.47M2024: $145.70M2025: $74.40M$74.40M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$74.40M-48.9%2024$145.70M+6.0%2023$137.47M-39.6%2022$227.54M-10.4%2021$253.91M+175.4%2020$92.20M+317.2%2019$22.10M+12.6%2018$19.63M+102.4%2017$9.70M-48.0%2016$18.64M-36.5%2015$29.37M-26.7%2014$40.06M-17.1%2013$48.30M+267.7%2012$13.14M-70.4%2011$44.39M+34.8%2010$32.93M-69.6%2009$108.25M+3.8%2008$104.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share